Class III
Terminated
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC.
Why: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
- Company
- GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Aiken, SC, United States - Reported
- Apr 30, 2014
- Recall started
- Feb 20, 2014
- Ended
- Jan 20, 2017
- Where sold
- U.S. Nationwide
- Amount
- 189,900 20 ct Vials, 145,068 81 ct Vials
- Full product description
- Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.
- Lots / codes affected
- (20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15)
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.